Education & Training Services
Compare Stocks
2 / 10Stock Comparison
UTI vs LPSN
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
UTI vs LPSN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Education & Training Services | Software - Application |
| Market Cap | $2.03B | $30M |
| Revenue (TTM) | $869M | $244M |
| Net Income (TTM) | $43M | $-67M |
| Gross Margin | 24.0% | 62.2% |
| Operating Margin | 6.3% | -9.6% |
| Forward P/E | 46.2x | — |
| Total Debt | $279M | $392M |
| Cash & Equiv. | $127M | $95M |
UTI vs LPSN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Universal Technical… (UTI) | 100 | 498.2 | +398.2% |
| LivePerson, Inc. (LPSN) | 100 | 0.4 | -99.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UTI vs LPSN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UTI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.89
- Rev growth 14.0%, EPS growth 50.7%, 3Y rev CAGR 25.9%
- 9.7% 10Y total return vs LPSN's -97.2%
In this particular matchup, LPSN is outpaced on most metrics by others in the set.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.0% revenue growth vs LPSN's -22.0% | |
| Quality / Margins | 4.9% margin vs LPSN's -27.6% | |
| Stability / Safety | Beta 0.89 vs LPSN's 2.05 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +25.5% vs LPSN's -80.6% | |
| Efficiency (ROA) | 5.2% ROA vs LPSN's -12.4%, ROIC 14.3% vs -6.6% |
UTI vs LPSN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
UTI vs LPSN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
UTI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UTI is the larger business by revenue, generating $869M annually — 3.6x LPSN's $244M. UTI is the more profitable business, keeping 4.9% of every revenue dollar as net income compared to LPSN's -27.6%. On growth, UTI holds the edge at +6.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $869M | $244M |
| EBITDAEarnings before interest/tax | $78M | -$562,000 |
| Net IncomeAfter-tax profit | $43M | -$67M |
| Free Cash FlowCash after capex | $2M | -$43M |
| Gross MarginGross profit ÷ Revenue | +24.0% | +62.2% |
| Operating MarginEBIT ÷ Revenue | +6.3% | -9.6% |
| Net MarginNet income ÷ Revenue | +4.9% | -27.6% |
| FCF MarginFCF ÷ Revenue | +0.2% | -17.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.7% | -19.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -95.2% | +79.4% |
Valuation Metrics
LPSN leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.0B | $30M |
| Enterprise ValueMkt cap + debt − cash | $2.2B | $327M |
| Trailing P/EPrice ÷ TTM EPS | 32.67x | -0.20x |
| Forward P/EPrice ÷ next-FY EPS est. | 46.23x | — |
| PEG RatioP/E ÷ EPS growth rate | 0.39x | — |
| EV / EBITDAEnterprise value multiple | 15.56x | — |
| Price / SalesMarket cap ÷ Revenue | 2.43x | 0.12x |
| Price / BookPrice ÷ Book value/share | 6.26x | — |
| Price / FCFMarket cap ÷ FCF | 36.70x | — |
Profitability & Efficiency
UTI leads this category, winning 7 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), UTI scores 7/9 vs LPSN's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +13.0% | — |
| ROA (TTM)Return on assets | +5.2% | -12.4% |
| ROICReturn on invested capital | +14.3% | -6.6% |
| ROCEReturn on capital employed | +14.7% | -5.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.85x | — |
| Net DebtTotal debt minus cash | $152M | $297M |
| Cash & Equiv.Liquid assets | $127M | $95M |
| Total DebtShort + long-term debt | $279M | $392M |
| Interest CoverageEBIT ÷ Interest expense | 166.10x | 0.20x |
Total Returns (Dividends Reinvested)
UTI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UTI five years ago would be worth $64,886 today (with dividends reinvested), compared to $33 for LPSN. Over the past 12 months, UTI leads with a +25.5% total return vs LPSN's -80.6%. The 3-year compound annual growth rate (CAGR) favors UTI at 82.0% vs LPSN's -66.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +48.6% | -35.5% |
| 1-Year ReturnPast 12 months | +25.5% | -80.6% |
| 3-Year ReturnCumulative with dividends | +503.3% | -96.1% |
| 5-Year ReturnCumulative with dividends | +548.9% | -99.7% |
| 10-Year ReturnCumulative with dividends | +970.1% | -97.2% |
| CAGR (3Y)Annualised 3-year return | +82.0% | -66.1% |
Risk & Volatility
UTI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
UTI is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than LPSN's 2.05 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UTI currently trades 91.4% from its 52-week high vs LPSN's 11.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 2.05x |
| 52-Week HighHighest price in past year | $40.41 | $21.60 |
| 52-Week LowLowest price in past year | $21.29 | $2.37 |
| % of 52W HighCurrent price vs 52-week peak | +91.4% | +11.6% |
| RSI (14)Momentum oscillator 0–100 | 59.7 | 41.2 |
| Avg Volume (50D)Average daily shares traded | 594K | 146K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | $49.00 | — |
| # AnalystsCovering analysts | 11 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 0 | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
UTI leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LPSN leads in 1 (Valuation Metrics).
UTI vs LPSN: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is UTI or LPSN a better buy right now?
For growth investors, Universal Technical Institute, Inc.
(UTI) is the stronger pick with 14. 0% revenue growth year-over-year, versus -22. 0% for LivePerson, Inc. (LPSN). Universal Technical Institute, Inc. (UTI) offers the better valuation at 32. 7x trailing P/E (46. 2x forward), making it the more compelling value choice. Analysts rate Universal Technical Institute, Inc. (UTI) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — UTI or LPSN?
Over the past 5 years, Universal Technical Institute, Inc.
(UTI) delivered a total return of +548. 9%, compared to -99. 7% for LivePerson, Inc. (LPSN). Over 10 years, the gap is even starker: UTI returned +970. 1% versus LPSN's -97. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — UTI or LPSN?
By beta (market sensitivity over 5 years), Universal Technical Institute, Inc.
(UTI) is the lower-risk stock at 0. 89β versus LivePerson, Inc. 's 2. 05β — meaning LPSN is approximately 129% more volatile than UTI relative to the S&P 500.
04Which is growing faster — UTI or LPSN?
By revenue growth (latest reported year), Universal Technical Institute, Inc.
(UTI) is pulling ahead at 14. 0% versus -22. 0% for LivePerson, Inc. (LPSN). On earnings-per-share growth, the picture is similar: Universal Technical Institute, Inc. grew EPS 50. 7% year-over-year, compared to 45. 4% for LivePerson, Inc.. Over a 3-year CAGR, UTI leads at 25. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — UTI or LPSN?
Universal Technical Institute, Inc.
(UTI) is the more profitable company, earning 7. 5% net margin versus -27. 6% for LivePerson, Inc. — meaning it keeps 7. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UTI leads at 10. 0% versus -9. 6% for LPSN. At the gross margin level — before operating expenses — LPSN leads at 62. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — UTI or LPSN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is UTI or LPSN better for a retirement portfolio?
For long-horizon retirement investors, Universal Technical Institute, Inc.
(UTI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), +970. 1% 10Y return). LivePerson, Inc. (LPSN) carries a higher beta of 2. 05 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UTI: +970. 1%, LPSN: -97. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between UTI and LPSN?
These companies operate in different sectors (UTI (Consumer Defensive) and LPSN (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.